Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection

Fig. 3

Levofloxacin delivered as nanoaerosol and standard aerosol. a Size distribution of nanoaerosolized levofloxacin generated from a 4 mg/mL levofloxacin solution in water. b Survival curve of mice treated with nanoaerosolized levofloxacin (blue) against 100LD50 intranasal F. novicida infection. c Survival curve of mice treated with 3-jet Collison nebulizer aerosolized levofloxacin (30 min—red, 1 h—green, 2 h—blue) against 100LD50 intranasal F. novicida infection

Back to article page